Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study

Abstract Background This study aimed to evaluate sickle-cell disease (SCD) treatment patterns and economic burden among patients prescribed hydroxyurea (HU) in the US, through claims data. Methods SCD patients with pharmacy claims for HU were selected from the Medicaid Analytic Extracts (MAX) from J...

Full description

Bibliographic Details
Published in:Health and Quality of Life Outcomes
Main Authors: Nirmish Shah, Menaka Bhor, Lin Xie, Rashid Halloway, Steve Arcona, Jincy Paulose, Huseyin Yuce
Format: Article
Language:English
Published: BMC 2019-10-01
Subjects:
Hydroxyurea
Adherence
Discontinuation
Health care
Cost
Utilization
Online Access:http://link.springer.com/article/10.1186/s12955-019-1225-7

Internet

http://link.springer.com/article/10.1186/s12955-019-1225-7

Similar Items